The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease
Megan E Astley(GGD Amsterdam), Sherin Manan, Anke Torp, Nicholas C Chesnaye(Amsterdam Neuroscience), Hans Schmidt-Gürtler, Christian Marx, Claudia Emde(Ludwig-Maximilians-Universität München), Justyna Mazur, Ines Schlee, Sabine Aign, Claudia Torino(Istituto di Fisiologia Clinica), Kirsten Anding‐Rost, Katja Blouin, Holger Naujoks, Christoph Wanner(Universitätsklinikum Würzburg), Eva Platen, Marie Evans(Karolinska University Hospital), Monika Hopf, Pawlos Ichtiaris, Kitty J. Jager(Amsterdam University Medical Centers), Katrin Neumeier, Christiane Drechsler(Universitätsklinikum Würzburg), Petra Kirste, Sabine Cäsar, Vianda S Stel(Amsterdam UMC Location University of Amsterdam), Gaetana Porto(Azienda ospedaliera "Bianchi-Melacrino-Morelli"), Nikolaus Frischmuth, Jochen Röthele, Petra Schulz, Sandra Biribauer, Hendrik Schlee, Boris Perras, Dunja Fuchs, Beate Iwig, Joachim Beige, Nadja Wuttke, Esther de Rooij(Leiden University Medical Center), Friedo W. Dekker(Leiden University Medical Center), Fergus Caskey, Maria Pippias(North Bristol NHS Trust), Christof Blaser, Detlef H. Krieter(Universitätsklinikum Würzburg), Andreas Schneider, Lothar Schramm, Kai Hahn, Ellen Irmler
Cited by 16
Related Papers
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
|New England Journal of Medicine|2016|3.6k
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|1k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886
An introduction to inverse probability of treatment weighting in observational research
|Clinical Kidney Journal|2021|877